发明名称 5-cyclo indole compounds
摘要 Described herein are compounds selective for a 5-HT1D-like receptor, which have the general formula: wherein A is selected from a six-membered, non-aromatic, optionally substituted carbocycle and a six-membered, non-aromatic, optionally substituted heterocycle having one or two heteroatoms selected from O, S, SO, SO2 and N4; R1 is selected from H and OH; n is 0 or 1 as permited by chemical structure; R2 is selected from CR5CR6CH2NR7R8 or a group of formula II, III or IV: R3 is selected from H and benzoyl; R4 is selected from H, loweralkyl, benzyl, loweralkylcarbonyl, loweralkylaminocarbonyl, loweralkylaminothiocarbonyl, loweralkanoyl, loweralkylaminoimide and loweralkoxy-substituted loweralkylene; R5 and R6 are independently selected from H, loweralkoxy and hydroxy; R7 and R8 are independently selected from H and loweralkyl or R7 and R8 form an alkylene bridge which, together with the nitrogen atom to which they are attached, creates an optionally substituted 3- to 6-membered ring; denotes a single or double bond; and R9, R10 and R11 are independently selected from H and loweralkyl. Also described is the use of these compounds as pharmaceuticals to treat indications where stimulation of a 5-HT1D-like receptor is implicated, such as migraine.
申请公布号 US5998438(A) 申请公布日期 1999.12.07
申请号 US19970976103 申请日期 1997.11.21
申请人 ALLELIX BIOPHARMACEUTICALS, INC. 发明人 SLASSI, ABDELMALIK;EDWARDS, LOUISE;MENG, QINGCHANG;RAKHIT, SUMANAS
分类号 C07D209/14;C07D209/18;C07D401/04;C07D401/14;C07D403/04;C07D403/06;C07D405/04;C07D405/14;(IPC1-7):C07D209/14;A61K31/40 主分类号 C07D209/14
代理机构 代理人
主权项
地址